Cencora, Inc. COR
306.92
(2.95)
(0.95%)
as of 25 Sep
- Market cap
- $59.1B
- P/E
- 22.7×
Follow COR
Indexes
indicate stock being part of an index,
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
Cencora, Inc. (COR) P/B ratio
As of 25 September 2026, Cencora, Inc. (COR) trades at a P/B ratio of 18.3×. Over the past ten years it has ranged from 0.0× (June 2021) to 509× (December 2022); the current reading is higher than 56% of that period. That is above the Healthcare sector median of 2.5×.
P/B ratio, daily
Annual
| Period | P/B ratio | Change |
|---|---|---|
| FY2025 | 34.7× | (38.95%) |
| FY2024 | 56.8× | 4.34% |
| FY2023 | 54.4× | (86.25%) |
| FY2022 | 396× | 840.49% |
| FY2021 | 42.1× | — |
| FY2020 | 0.0× | — |
| FY2019 | 5.8× | (12.79%) |
| FY2018 | 6.6× | (24.77%) |
| FY2017 | 8.8× | 9.46% |
| FY2016 | 8.1× | (76.01%) |
Quarterly
| Period | P/B ratio | Change |
|---|---|---|
| Jun 2026 | 16.9× | (1.02%) |
| Mar 2026 | 17.0× | (45.53%) |
| Dec 2025 | 31.3× | (9.73%) |
| Sep 2025 | 34.7× | 31.84% |
| 42 more quarters | Free account |
Against its own ten years
Low 0.0×
High 509×
Ten-year median
13.9×
Current reading's percentile
56
P/B ratio against peers
| Company | P/B ratio |
|---|---|
| MCK McKesson Corporation compare | n/m |
| ACH Accendra Health, Inc. compare | n/m |
| CAH Cardinal Health, Inc. compare | n/m |
| FOCL FocalTherics compare | n/m |
| YI 111, Inc. Sponsored ADR compare | n/m |
| AHG Akso Health Group Sponsored ADR compare | 0.1× |
| COSM Cosmos Health Inc. compare | 1.0× |
| HSIC Henry Schein, Inc. compare | 2.6× |
| COR Cencora, Inc. | 18.3× |
| Healthcare sector median | 2.5× |
| Market median | 1.8× |
What P/B ratio is
Price to Book Value tells an investor how much the market pays for a company’s shares relative to the accounting net worth that belongs to common shareholders.
Stock Price ÷ (Common Equity (Total) (latest quarter) ÷ Shares (Basic, Weighted) (latest quarter))
More on COR
- Revenue
- Net income
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- The full statement